Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://chrysbio.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Home - Chrysalis BioTherapeutics, |
Description | Saving Lives Through Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation |
Keywords | N/A |
WebSite | chrysbio.com |
Host IP | 185.133.206.186 |
Location | - |
Site | Rank |
US$635,179
Last updated: 2023-05-08 03:03:15
chrysbio.com has Semrush global rank of 16,663,499. chrysbio.com has an estimated worth of US$ 635,179, based on its estimated Ads revenue. chrysbio.com receives approximately 73,290 unique visitors each day. Its web server is located in -, with IP address 185.133.206.186. According to SiteAdvisor, chrysbio.com is safe to visit. |
Purchase/Sale Value | US$635,179 |
Daily Ads Revenue | US$587 |
Monthly Ads Revenue | US$17,590 |
Yearly Ads Revenue | US$211,075 |
Daily Unique Visitors | 4,886 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
chrysbio.com. | A | 3600 | IP: 185.133.206.186 |
chrysbio.com. | NS | 86400 | NS Record: ns2.bdm.microsoftonline.com. |
chrysbio.com. | NS | 86400 | NS Record: ns3.bdm.microsoftonline.com. |
chrysbio.com. | NS | 86400 | NS Record: ns4.bdm.microsoftonline.com. |
chrysbio.com. | NS | 86400 | NS Record: ns1.bdm.microsoftonline.com. |
chrysbio.com. | MX | 3600 | MX Record: 0 chrysbio-com.mail.protection.outlook.com. |
chrysbio.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
chrysbio.com. | TXT | 3600 | TXT Record: mscid=GzVSsqQedyoZ4d6uIv5gd8WWRzQHbZI7jnEMf4dHHbH9pS83rj/raNHqBmOnQTrTzgn3/mtCCS3k/IQ6uKlZgg== |
Home About Us Science & Tech TP508 Peptide Technology Covid-19 Respiratory Failure (ARDS) Nuclear Radiation Exposure Pipeline News Contact Home About Us Science & Tech TP508 Peptide Technology Covid-19 Respiratory Failure (ARDS) Nuclear Radiation Exposure Pipeline News Contact Saving Lives Through Innovation Chrysalis BioTherapeutics, Inc . is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure Contact us OUR RESEARCH Our Innovative Solutions TP508 Peptide Technology The TP508 thrombin peptide is released locally following vascular injury to initiate cellular regenerative processes that lead to revascularization, stem cell activation, and tissue repair. Read more Covid-19 TP508, targets endothelial cells to restore vascular function and modulate immune responses after injury. A single injection of TP508 24 hours after SARS-CoV-2 infection almost completely blocks the CoV-2 |
HTTP/1.1 301 Moved Permanently Server: nginx Date: Fri, 29 Oct 2021 05:41:39 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://chrysbio.com/ HTTP/2 200 server: nginx date: Fri, 29 Oct 2021 05:41:39 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-powered-by: PHP/7.4.25 last-modified: Mon, 25 Oct 2021 11:37:22 GMT cache-control: max-age=0 expires: Fri, 29 Oct 2021 05:41:39 GMT vary: Accept-Encoding |
Domain Name: CHRYSBIO.COM Registry Domain ID: 1714667732_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-04-19T08:48:07Z Creation Date: 2012-04-20T02:06:32Z Registry Expiry Date: 2022-04-20T02:06:32Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.BDM.MICROSOFTONLINE.COM Name Server: NS2.BDM.MICROSOFTONLINE.COM Name Server: NS3.BDM.MICROSOFTONLINE.COM Name Server: NS4.BDM.MICROSOFTONLINE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T20:05:34Z <<< |